Small Molecule Disruptors of the Glucokinase–Glucokinase Regulatory Protein Interaction: 1. Discovery of a Novel Tool Compound for in Vivo Proof-of-Concept
- 9 January 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 57 (2) , 309-324
Abstract
Small molecule activators of glucokinase have shown robust efficacy in both preclinical models and humans. However, overactivation of glucokinase (GK) can cause excessive glucose turnover, leading to hypoglycemia. To circumvent this adverse side effect, we chose to modulate GK activity by targeting the endogenous inhibitor of GK, glucokinase regulatory protein (GKRP). Disrupting the GK-GKRP complex results in an increase in the amount of unbound cytosolic GK without altering the inherent kinetics of the enzyme. Herein we report the identification of compounds that efficiently disrupt the GK-GKRP interaction via a previously unknown binding pocket. Using a structure-based approach, the potency of the initial hit was improved to provide 25 (AMG-1694). When dosed in ZDF rats, 25 showed both a robust pharmacodynamic effect as well as a statistically significant reduction in glucose. Additionally, hypoglycemia was not observed in either the hyperglycemic or normal rats.Keywords
This publication has 28 references indexed in Scilit:
- GKAs for diabetes therapy: why no clinically useful drug after two decades of trying?Trends in Pharmacological Sciences, 2013
- Small molecular glucokinase activators: has another new anti‐diabetic therapeutic lost favour?British Journal of Pharmacology, 2012
- Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 DiabetesDiabetes Care, 2011
- Glucokinase Activators for Diabetes TherapyDiabetes Care, 2011
- Glucokinase activators as potential antidiabetic agents possessing superior glucose lowering efficaciesDrugs of the Future, 2009
- Glucokinase Activators for the Potential Treatment of Type 2 DiabetesCurrent Topics in Medicinal Chemistry, 2008
- Glucokinase and molecular aspects of liver glycogen metabolismBiochemical Journal, 2008
- Glucokinase activators in diabetes managementExpert Opinion on Investigational Drugs, 2008
- Glucokinase (GCK) mutations in hyper- and hypoglycemia: Maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancyHuman Mutation, 2003
- Glucokinase as Glucose Sensor and Metabolic Signal Generator in Pancreatic β-Cells and HepatocytesDiabetes, 1990